RAmucirumab Combined wIth Standard Nab-paclitaxel and Gemcitabine as First-line Chemotherapy in Patients With Advanced Pancreatic Adenocarcinoma
Clinical trial NCT03745430 · COMPLETED
Trial details
- NCT number
- NCT03745430
- Sponsor
- Hellenic Cooperative Oncology Group
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-01-29
- Primary completion
- 2022-06-17
- Enrollment
- 54
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.